Oracle (NYSE:ORCL) Stock Keeps “Overweight” Rating at Cantor Fitzgerald

Oracle (NYSE:ORCL)‘s stock had its “overweight” rating restated by Cantor Fitzgerald in a research note issued to investors on Thursday, Benzinga reports. They presently have a $284.00 price target on the enterprise software provider’s stock. Cantor Fitzgerald‘s price objective would suggest a potential upside of 119.98% from the stock’s previous close.

A number of other equities analysts have also recently issued reports on ORCL. Scotiabank lowered their target price on Oracle from $241.00 to $215.00 and set a “sector outperform” rating for the company in a report on Wednesday, September 9th. Royal Bank Of Canada cut their price target on Oracle from $190.00 to $165.00 and set a “sector perform” rating on the stock in a research note on Friday, September 11th. Morgan Stanley lifted their price target on Oracle from $207.00 to $210.00 and gave the company an “equal weight” rating in a research note on Friday, September 4th. President Capital reduced their price target on Oracle from $360.00 to $300.00 and set an “overweight” rating on the stock in a report on Tuesday, July 14th. Finally, UBS Group upped their price objective on Oracle from $245.00 to $250.00 and gave the company a “buy” rating in a research note on Friday, September 11th. One investment analyst has rated the stock with a Strong Buy rating, thirty-five have assigned a Buy rating, nine have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, Oracle has an average rating of “Moderate Buy” and a consensus target price of $249.52.

Oracle Price Performance

ORCL stock opened at $129.10 on Thursday. The company has a 50 day simple moving average of $144.17 and a 200 day simple moving average of $158.44. The stock has a market cap of $390.36 billion, a price-to-earnings ratio of 20.24, a P/E/G ratio of 0.93 and a beta of 1.78. Oracle has a 1 year low of $114.50 and a 1 year high of $287.19. The company has a debt-to-equity ratio of 1.89, a current ratio of 1.17 and a quick ratio of 1.17.

Oracle (NYSE:ORCL) last issued its quarterly earnings data on Thursday, September 10th. The enterprise software provider reported $1.92 EPS for the quarter, beating the consensus estimate of $1.74 by $0.18. The business had revenue of $19.35 billion during the quarter, compared to the consensus estimate of $19.13 billion. Oracle had a net margin of 26.36% and a return on equity of 48.85%. The firm’s revenue was up 29.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.47 EPS. Oracle has set its Q2 2027 guidance at 1.850-1.930 EPS and its FY 2027 guidance at 8.100-8.100 EPS. Research analysts anticipate that Oracle will post 6.73 EPS for the current fiscal year.

Insider Buying and Selling at Oracle

In other Oracle news, EVP Maria Smith sold 2,631 shares of the company’s stock in a transaction dated Tuesday, September 22nd. The stock was sold at an average price of $151.70, for a total value of $399,122.70. Following the sale, the executive vice president owned 64,357 shares in the company, valued at approximately $9,762,956.90. The trade was a 3.93% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Stephen Rusckowski purchased 25,000 shares of the firm’s stock in a transaction dated Tuesday, September 29th. The stock was bought at an average cost of $139.35 per share, with a total value of $3,483,750.00. Following the purchase, the director owned 25,390 shares of the company’s stock, valued at approximately $3,538,096.50. This trade represents a 6,410.26% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. In the last quarter, insiders have sold 36,075 shares of company stock worth $5,342,123. Insiders own 38.40% of the company’s stock.

Institutional Trading of Oracle

A number of institutional investors and hedge funds have recently added to or reduced their stakes in ORCL. Sherman Asset Management Inc. boosted its stake in shares of Oracle by 5.5% in the 1st quarter. Sherman Asset Management Inc. now owns 1,054 shares of the enterprise software provider’s stock valued at $155,000 after purchasing an additional 55 shares during the last quarter. Global Financial Private Client LLC raised its stake in Oracle by 0.8% during the first quarter. Global Financial Private Client LLC now owns 7,836 shares of the enterprise software provider’s stock worth $1,153,000 after buying an additional 59 shares during the last quarter. Key Financial Inc raised its stake in Oracle by 0.4% during the first quarter. Key Financial Inc now owns 14,203 shares of the enterprise software provider’s stock worth $2,089,000 after buying an additional 62 shares during the last quarter. Gould Asset Management LLC CA raised its stake in Oracle by 2.0% during the first quarter. Gould Asset Management LLC CA now owns 3,172 shares of the enterprise software provider’s stock worth $467,000 after buying an additional 62 shares during the last quarter. Finally, One Charles Private Wealth Services LLC lifted its holdings in Oracle by 1.6% in the first quarter. One Charles Private Wealth Services LLC now owns 3,859 shares of the enterprise software provider’s stock valued at $568,000 after buying an additional 62 shares during the period. Institutional investors and hedge funds own 42.44% of the company’s stock.

More Oracle News

Here are the key news stories impacting Oracle this week:

• Positive Sentiment: Oracle’s AI and cloud strategy continues to generate commercial momentum. The company launched Fusion Claw agentic HR applications and AI Agent Studio for industry-specific workflows, potentially increasing the value of its Fusion Cloud platform and supporting enterprise demand. Oracle Introduces Claw-Powered Fusion Agentic Applications for HR
• Positive Sentiment: AstraZeneca is working with Oracle on AI tools to identify clinical-trial candidates and connect research data with healthcare workflows. The partnership expands Oracle’s healthcare opportunity and provides a high-profile validation of its AI capabilities, although the agreement is not expected to create material near-term revenue. Oracle Expands Its AI Healthcare Push With a New Drugmaker Partnership
• Positive Sentiment: TD Cowen suggested Nvidia may be helping Oracle finance or otherwise support its AI data-center build-out. Separately, a proposed push for data centers to generate their own electricity could help address power constraints and enable additional capacity, though it may also increase Oracle’s capital requirements. Nvidia May Be Helping Finance Oracle’s AI Data Centers
• Neutral Sentiment: Analysts and investors remain divided: Bank of America sees substantial upside from Oracle’s growth, while comparisons with Microsoft highlight Oracle’s faster cloud expansion but weaker free-cash-flow profile and heavier debt burden. Oracle’s multicloud database growth is another potentially important long-term catalyst.
• Negative Sentiment: The main pressure point is funding. Oracle’s cloud backlog reportedly exceeds $664 billion, but free cash flow is deeply negative as it accelerates AI infrastructure spending. Concerns that borrowing could threaten Oracle’s credit rating—and potentially lead to bond downgrades—are weighing on the stock. Oracle’s Growth to Valuation Mismatch is Less and Less Compelling
• Negative Sentiment: Reports that Oracle may face broader obligations related to human-resources AI agents, combined with concerns over delays and a force-majeure claim involving its large New Mexico data-center project, have reinforced worries about execution, costs, and customer commitments. Oracle Stocks Fall as HR Agents Broaden the RPO Burden

About Oracle

Oracle Corporation (NYSE: ORCL) is a global technology company that develops enterprise software, cloud infrastructure and database technologies. Its products help organizations store, manage, analyze and secure data, while supporting business operations across industries and geographies.

The company’s offerings include Oracle Database, Java, Oracle Cloud Infrastructure and a broad portfolio of cloud-based applications. These applications serve functions such as enterprise resource planning, financial management, human resources, supply-chain management, customer experience and industry-specific operations.